ANEES A FAZILI
Allopathic & Osteopathic Physicians|Urology ROCHESTER, NY NPI 1114169372
Browse related groups: Allopathic & Osteopathic Physicians|Urology NY PROCEPT BioRobotics Corporation All categories
General Payments — all program years on this page
$9,779.74
- Category: General Payments
- Program years: PY2018–2024
- Record count: 390
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,843.71 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,020.47 | 75 |
| Travel and Lodging | $823.24 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PROCEPT BioRobotics Corporation | $1,111.70 | 6 |
| EDAP TECHNOMED INC | $339.00 | 3 |
| ABBVIE INC. | $174.61 | 8 |
| PFIZER INC. | $127.48 | 7 |
| Medtronic, Inc. | $84.87 | 3 |
| Janssen Biotech, Inc. | $84.52 | 4 |
| Merck Sharp & Dohme Corporation | $82.68 | 4 |
| Sumitomo Pharma America, Inc. | $73.56 | 4 |
| Astellas Pharma US Inc | $72.52 | 4 |
| COLOPLAST CORP | $68.41 | 3 |
| ACCORD HEALTHCARE, INC. | $62.20 | 3 |
| TOLMAR, INC. | $60.73 | 3 |
| Blue Earth Diagnostics Limited | $58.30 | 3 |
| UROGEN PHARMA, INC. | $45.45 | 2 |
| C. R. BARD, INC. & SUBSIDIARIES | $44.93 | 1 |
| Teleflex LLC | $43.07 | 2 |
| Endo Pharmaceuticals Inc. | $42.67 | 2 |
| Myriad Genetic Laboratories, Inc. | $34.49 | 2 |
| Telix Pharmaceuticals | $31.77 | 2 |
| Ambu Inc. | $31.00 | 2 |
| Olympus America Inc. | $24.65 | 1 |
| Endo USA, Inc. | $20.70 | 1 |
| Axonics Modulation Technologies, Inc. | $20.10 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.96 | 1 |
| Tempus AI, Inc | $18.40 | 1 |
| IMMUNITYBIO, INC. | $17.57 | 1 |
| Cook Medical LLC | $16.83 | 1 |
| Novo Nordisk AS | $16.03 | 1 |
| Ferring Pharmaceuticals Inc. | $15.51 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.